FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
The VA’s Journey with Early Adoption of AI in Healthcare
Internet Use and Adolescent Mental Health: The Role of Parental Support
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Enhancing Global Health through Regulatory Collaboration
Enhancing Child Mental Health Services with Digital Interventions
The Trump Drug Policy Change: A Reverse Course
Created and Validated by FDA: AI Drug Safety Surveillance Tool
The Role of School-Based Health Centres in Advancing Health Equity
Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism
Eli Lilly’s Alzheimer’s Drug Kisunla Gains Approval in Japan
Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools
The Effect of Sedentary Behaviour on Healthy Ageing